Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Thyroiditis

sorafenib has been researched along with Thyroiditis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzhanova, YB; Gribanova, EO; Parovichnikova, EN; Ryzhko, VV; Samtsova, MA; Sokolov, AN1
Han, XY; Hu, J; Huang, H; Huang, Y; Sun, J; Ying, SW; Zheng, YL1
Beck-Peccoz, P; Fugazzola, L; Iavarone, M; Perrino, M; Viganò, M1
Eskens, FA; Mathijssen, RH; Peeters, RP; van der Lugt, A; van Doorn, L; Visser, TJ1

Other Studies

4 other study(ies) available for sorafenib and Thyroiditis

ArticleYear
[Sorafenib - induced thyroiditis in patient with a relapse of acute myelomonocytic leukemia with FLT3-ITD mutation].
    Terapevticheskii arkhiv, 2019, Aug-15, Volume: 91, Issue:8

    Topics: Antineoplastic Agents; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Mutation; Recurrence; Sorafenib; Thyroiditis

2019
Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia.
    Chinese medical journal, 2016, 10-20, Volume: 129, Issue:20

    Topics: Adult; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Niacinamide; Phenylurea Compounds; Sorafenib; Tandem Repeat Sequences; Thyroiditis

2016
Sorafenib-induced destructive thyroiditis.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:9

    Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chronic Disease; Hepatitis B, Chronic; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prednisone; Propranolol; Protein Kinase Inhibitors; Pyridines; Sorafenib; Technetium; Thyroiditis

2010
Sorafenib induced thyroiditis in two patients with hepatocellular carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:2

    Topics: Aged; Antineoplastic Agents; Atrophy; Benzenesulfonates; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Thyroid Gland; Thyroiditis; Ultrasonography

2011